Godfrey Pimundu

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation

Claire D. Bourke, Ethan Gough, Godfrey Pimundu et al. · Science Translational Medicine · 2019 · 107 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

Andrew J. Prendergast, Alexander J. Szubert, Chipo Berejena et al. · The Journal of Infectious Diseases · 2016 · 21 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa

Andrew J. Prendergast, Alexander J. Szubert, Godfrey Pimundu et al. · AIDS · 2021 · 14 citations · Full text

Public Health, Immunology, Infectious Diseases +16

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

Cissy Kityo, David Dunn, Anne Hoppé et al. · Clinical Infectious Diseases · 2018 · 12 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17